Mandatory Reporting of 'Non-Covered Medical Services' to All Hospitals and Clinics Starting Next Year

Starting with 672 Items First... Expanded to 90% of All Non-Covered Services in 2024

[Asia Economy Reporter Jo In-kyung] A system that obligates all medical institutions to report non-reimbursable items, amounts, and treatment details is being promoted.

The Ministry of Health and Welfare announced on the 16th that it has issued a legislative notice for the full revision of the "Standards for Reporting and Disclosure of Non-Reimbursable Medical Costs" and will accept opinions until the 25th of next month.

According to the revision, starting in 2023, all medical institutions must report to the Ministry of Health and Welfare the costs of non-reimbursable items, number of treatments, target diseases, and the names of surgeries or procedures performed for 672 items, including 611 non-reimbursable items and 61 new medical technologies.

From 2024, the reporting scope will expand to 1,212 items, accounting for about 90% of the total non-reimbursable scale. This includes therapeutic non-reimbursable items, drugs, nutritional injections, vaccinations, dental orthodontics, and herbal medicine prescriptions.

Reporting frequency will be twice a year in March and September for hospital-level institutions, and once a year in March for clinic-level institutions. The National Health Insurance Service and the Health Insurance Review & Assessment Service will be responsible for reporting-related tasks, and to reduce administrative burdens on medical institutions, a program that automatically extracts the necessary data for reporting will be developed and supported.

The Ministry of Health and Welfare previously identified the status of non-reimbursable items and promoted related policies based on the results of a medical cost survey conducted by the National Health Insurance Service through sample surveys. However, with the revision of the notice, it is expected to obtain more detailed information related to non-reimbursable items. A ministry official stated, "We plan to closely monitor the status of non-reimbursable items to support the establishment of evidence-based non-reimbursable management policies and strengthen the provision of non-reimbursable information to medical consumers."

This content was produced with the assistance of AI translation services.